JiscMail Logo
Email discussion lists for the UK Education and Research communities

Help for ACB-CLIN-CHEM-GEN Archives


ACB-CLIN-CHEM-GEN Archives

ACB-CLIN-CHEM-GEN Archives


ACB-CLIN-CHEM-GEN@JISCMAIL.AC.UK


View:

Message:

[

First

|

Previous

|

Next

|

Last

]

By Topic:

[

First

|

Previous

|

Next

|

Last

]

By Author:

[

First

|

Previous

|

Next

|

Last

]

Font:

Proportional Font

LISTSERV Archives

LISTSERV Archives

ACB-CLIN-CHEM-GEN Home

ACB-CLIN-CHEM-GEN Home

ACB-CLIN-CHEM-GEN  September 2011

ACB-CLIN-CHEM-GEN September 2011

Options

Subscribe or Unsubscribe

Subscribe or Unsubscribe

Log In

Log In

Get Password

Get Password

Subject:

transferrin saturation - summary of replies - sorry for the delay

From:

Louise Ward <[log in to unmask]>

Reply-To:

Louise Ward <[log in to unmask]>

Date:

Thu, 8 Sep 2011 09:07:28 +0100

Content-Type:

text/plain

Parts/Attachments:

Parts/Attachments

text/plain (1 lines)

Dear All,

Thanks very much to all who replied to my previous question about transferrin saturation, here is the summary of the replies, I apologise for the delay.



Question:

Dear all,



I’d very much appreciate help regarding how to calculate transferrin saturation (%) using measured molar concentrations of serum iron and transferrin.  I have found an equation, but only in ‘lecture notes’ and the like on the internet, and I would like to check this out…

We are considering adding this in to our iron studies report with serum iron, transferrin and ferritin.  Is this in keeping with others out there?



Assuming each transferrin molecule can bind two Fe3+ ions transferrin saturation can be calculated  ~

Transferrin saturation % = (iron mol/L x 100)/(transferrin mol/L x 2)



Thank you very much, best wishes, Lou



Replies:

1.  Obviously not facing demands to make testing appropriate - saturation not required in most ?Fe deficiency. Guidance here [from haematologists] is that ferritin should be used as frontline test for Fe Deficiency



2.  I agree that ferritin should be used for iron deficiency, however Transferrin saturation is useful for the investigation of possible haemochromatosis. The difficulty with the calculation is that the molecular weight of transferrin is not clearly defined, therefore the conversion from g/L to mol/L can be variable depending on what figure you use.



3.  I agree with your equation for transferrin saturation but the crux of the matter is what molecular weight to use to convert gravimetric transferrin concentration to molar units.  There seems to be quite a wide range of figures used – and some labs “fiddle” their equation so that the calculated TIBC agrees better with EQA.



4.  Here in Wales we’re having to grapple with this problem as the introduction of a national LIMS requires us to all work in the same way as far as is possible.  We are fairly certain that transferrin from North Wales has the same molecular weight as that in the South!



I would suggest using a molecular weight for transferrin of 79,570 (MacGillvray RTA et al, The Primary Structure of Human Serum Transferrin. J Biol Chem 1983; 258: 3543-53) which is in close agreement with a later measurement (79,680 by  Zhao YY et al, Intact human holo-transferrin interaction with oxaloplatin. Rapid Commun Mass Spectrom 2005; 19:1956-1962).







The calculation is:



TF saturation = (serum iron (umol/L)/total iron binding capacity (umol/L)) x 100



Total iron binding capacity (umol/L) = Transferrin (umol/L) x 2        (assumes transferrin binds two ions of iron per molecule)



Transferrin (umol/L) = (Transferrin (g/L) / Mol wt transferrin) x 10^6



Final calculation is



            TF saturation (%) = serum iron [umol/L] x 100 / (Transferrin [g/L] x10^6 x2/79,570)



Which simplifies down to



            TF saturation (%) = serum iron [umol/L] x 3.98 / Transferrin [g/L]



(i.e. factor (3.98) = mol wt transferrin  x 100 / 2 x 10^6)



We tend not to measure it if ferritin is <15 ug/L even if it has been requested.  If requested then we will assay it if ferritin is between 15 & 100, or above 300 – the logic being that below 100 it is possible for an acute phase response/malignancy/chronic illness to increase ferritin even in the face of iron deficiency (I also accept the logic that transferrin is a negative acute phase protein and therefore transferrin saturation is not likely to be very helpful – so we’re not completely logical!) and if ferritin is above 300 we need to exclude the possibility of iron overload.



5.  Transferrin in µmol/L looks very unfamiliar to me.

Do you report transferrin as molar concentration to requesting physicians ? Does it also apply for ferritin (this would confuse me even more) ?

What about other proteins (albumin, antitrypsin or similar) ?



6.  I agree with you. Maybe I am a bit naïve, but surely molar quantities of any protein is technically meaningless? As most circulating proteins are not chemically homogenous, but have varying degress of modification, they must have an indefinite molar mass - converting mass to moles is not sensible.



Or have I missed something?



7.  µmol/L transferrin equals µmol/L of transferrin iron-binding sites divided by 2



transferrin (g/L) x 12.6 ==> transferrin (µmol/L)



(source: Ref ranges for adults and Children 8th edition 2004, Heil W., Koberstein R. and Zawta B.)



8.  I understand that you report transferrin in umol/L and that your manufacturer uses a molecular mass of 79,570 to convert from mass to molar units.  The conversion factor depends on what you believe the molecular mass to be.  Recently I’ve looked at the equations used within Wales for the calculation of transferrin saturation and the apparent molecular mass for transferrin used in those calculations ranged from 75,188 to 90,909 which goes some way to explaining variability in transferrin saturation on EQA returns!  With the pending introduction of a national pathology LIMS in Wales we have decided to standardise on a figure of 79,570 (MacGillvray RTA et al, The Primary Structure of Human Serum Transferrin. J Biol Chem 1983; 258: 3543-53 ) which is in close agreement with a later measurement of 79,680 by Zhao YY et al, Intact human holo-transferrin interaction with oxaloplatin. Rapid Commun Mass Spectrom 2005; 19:1956-1962.



Slightly off the original thread – but could we as a community agree on an equation for the calculation of transferrin saturation? i.e. all use the same molecular mass in the calculation.



9.  This is very topical.



We (DH, CfH, Prof Bodies incl ACB)  are currently trying to agree standard units for pathology reporting across the NHS as there are considerable nmbers of errors visible in current electronic reporting messages.



If you wish to see current "draft" recommendations or to contribute to the work please take a look at



www.ychi.leeds.ac.uk/pmipunits<http://www.ychi.leeds.ac.uk/pmipunits> (cut and paste if the link doesn't click through)



10.  We use Transferrin saturation (%)= (Iron umol/L /Transferrin g/L ) x 3.98



11.  If there are two eggs in an eggbox which has a capacity to hold six eggs then the box is 30%full; you don't multiply the box by it's capacity. Hence, % saturation is ([iron]/[transferrin]*100. The reference range will depend on the ratio between transferrin expressed as 'g' and 'mols'.



12.  Except...



If you've measured both eggs and eggboxes in molar units. You'd then have 1 eggbox, 2 eggs and ([eggs]/[eggbox] x100) would give you 200%.



13.  IRON STUDIES



Iron:

8.1 - 28.6 µmol/L (male)

5.4 - 28.6 µmol/L (female)

Transferrin: 2.0 - 3.6 g/L

Transferrin binds 2 atoms of iron when fully saturated.

Transferrin % saturation = (2 x iron x 0.07957)/transferrin

Transferrin index >1 compatible with iron overload - ?haemochromatosis

I hope this is helpful,



14.  There is little point in measuring iron (poisoning excluded and there is no need to measure TIBC in a case of poisoning), transferrin is an acute phase reactant which complicates the situation, then to make matters worse there is anaemia of chronic disorder.



If it's necessary to assess an individual's iron status then we should measure' hepcidin'; those of us old enough will remember reading the elctrolyte section in books referring to the 'third factor' before natriuretic hormones were discovered.



15.  So why do we not all measure UIBC/TIBC and iron to produce a real saturation ?



16.  When we assay serum iron concentration, usually most of the iron is bound to transferrin, but some is not (some may be bound to other proteins, some may be free or unbound, and the magnitude of these components is unknown).



When we determine UIBC or TIBC, we are determining the uptake of iron by proteins in the serum, mostly by transferrin, but some by other proteins (and the magnitude of this component is unknown).





So a transferrin saturation calculated from these measurements is no more “real” than one calculated from serum iron and transferrin calculations.



17.  Derived TIBC

We report:

•       iron

•       dTIBc (from the measured transferrin)

•       % saturation.

We measure transferrin in g/L and then convert it to micromol/L.  For that you need the m.w.  we use 87,900 but it would appear Wales use 79,570



Thus

1 g/L Transferrin = 11.4 micromoles/L using 87,900 or

1 g/L Transferrin = 12.6 micromol/L using 79,570.



As there are 2 iron binding sites, then the TIBC is twice the concentration in micromoles.



Thus 1

1 g/L Transferrin = 11.4 micromol/L = dTIBC of 22.8 micromoles/L using 87,900  or

1 g/L Transferrin = 12.6 micromol/L  = dTIBC of 25.2 micromoles/L using 79,570.



% saturation is (iron/dTIBC)*100% with both iron and dTIBC in micromol/L, which is the same as your calculation (except your calculation uses transferrin and not dTIBC)



Thus the key is what molecular weight to use.  The Welsh are a good bunch and it may be that I will re look at the m.w. that we use. However we look good in NEQAS albeit a bit high (even though they do not score it).  If we were to use a higher conversion factor, a la Wales, then our results will be even higher.  So perhaps we are using the better m.w.







*********************************************************************************************

www.bedfordhospital.nhs.uk



*********************************************************************************************

This email is confidential and privileged. If you are not the intended recipient please accept our apologies. Please do not disclose, copy or distribute information in this email or take any action in reliance on its contents; to do so is strictly prohibited and may be unlawful. Please inform us that this email has gone astray before deleting it. Thank you for your co-operation.



*********************************************************************************************



------ACB discussion List Information--------

This is an open discussion list for the academic and clinical community working in clinical biochemistry.

Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content.

ACB Web Site

http://www.acb.org.uk

Green Laboratories Work

http://www.laboratorymedicine.nhs.uk

List Archives

http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html

List Instructions (How to leave etc.)

http://www.jiscmail.ac.uk/

Top of Message | Previous Page | Permalink

JiscMail Tools


RSS Feeds and Sharing


Advanced Options


Archives

April 2024
March 2024
February 2024
January 2024
December 2023
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
March 2023
February 2023
January 2023
December 2022
November 2022
October 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
2006
2005
2004
2003
2002
2001
2000
1999
1998


JiscMail is a Jisc service.

View our service policies at https://www.jiscmail.ac.uk/policyandsecurity/ and Jisc's privacy policy at https://www.jisc.ac.uk/website/privacy-notice

For help and support help@jisc.ac.uk

Secured by F-Secure Anti-Virus CataList Email List Search Powered by the LISTSERV Email List Manager